Temozolomide and irinotecan for relapsed glioma: Charing Cross Hospital experience

A. G. Young,Paul Mulholland,Adam D. Waldman,Federico Roncaroli,Kevin ONeill,S. J. Davidson,M.G. Glaser,Cathryn S. Brock,E.S. Newlands

Temozolomide and irinotecan for relapsed glioma: Charing Cross Hospital experience

2007

A. G. Young
Paul Mulholland
Adam D. Waldman
Federico Roncaroli
Kevin ONeill
S. J. Davidson
M.G. Glaser
Cathryn S. Brock
E.S. Newlands

12504 Background: Patients (pts) with relapsed glioma have poor prognosis with few treatment options. Methods: Retrospective analysis was made of toxicity and outcome in pts with relapsed glioma tr...

Keywords:

Temozolomide
Glioma
Cancer research
Irinotecan
Medicine
poor prognosis
Pathology
Internal medicine
hospital experience
Oncology
retrospective analysis
treatment options

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations